Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2011-01-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3275/7481PMID 21270509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas

  2009cited by this paper
• Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma

  2008cited by this paper
• Effect of 9-cis Retinoic Acid on Dopamine D2 Receptor Expression in Pituitary Adenoma Cells

  2008cited by this paper
• Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat

  2008cited by this paper
• Estrogen Receptors in Human Pituitary Tumors

  2008cited by this paper
• Mammalian Bombesin Receptors : Nomenclature , Distribution , Pharmacology , Signaling , and Functions in Normal and Disease States

  2008cited by this paper
• International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States

  2008cited by this paper
• Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma

  2007cited by this paper
• Accumulation of retinoid X receptor-alpha in uterine leiomyomas is associated with a delayed ligand-dependent proteasome-mediated degradation and an alteration of its transcriptional activity.

  2007cited by this paper
• Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

  2007cited by this paper
• Gene expression profiling in human null cell pituitary adenoma tissue

  2007cited by this paper
• Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

  2006cited by this paper
• Colorectal cancer: a model for epigenetic tumorigenesis

  2006cited by this paper
• Metallothionein Isoform 3 Gene Is Differentially Expressed in Corticotropin-Producing Pituitary Adenomas

  2006cited by this paper
• Expression of the RERG Gene is Gender-Dependent in Hepatocellular Carcinoma and Regulated by Histone Deacetyltransferases

  2006cited by this paper
• Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies

  2006cited by this paper
• CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies

  2006cited by this paper
• ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis

  2006cited by this paper
• Cellular Retinoic Acid Binding Protein I: Expression and Functional Influence in Renal Cell Carcinoma

  2005cited by this paper
• Differential gene expression in pituitary adenomas by oligonucleotide array analysis.

  2005cited by this paper
• Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.

  2005cited by this paper
• The effect of cellular retinoic acid binding protein-I expression on the CYP26-mediated catabolism of all-trans retinoic acid and cell proliferation in head and neck squamous cell carcinoma.

  2004cited by this paper
• TIMP1 and SERPIN‐A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma

  2004cited by this paper
• Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium.

  2002cited by this paper
• Gastrin-Releasing Peptide Is a Growth Factor for Human Neuroblastomas

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Retinoic acid prevents experimental Cushing syndrome.

  2001cited by this paper
• RERG Is a Novel ras-related, Estrogen-regulated and Growth-inhibitory Gene in Breast Cancer*

  2001cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Novel Patterns of Gene Expression in Pituitary Adenomas Identified by Complementary Deoxyribonucleic Acid Microarrays and Quantitative

  2000cited by this paper
• Primer3 on the WWW for general users and for biologist programmers.

  2000cited by this paper
• CpG island methylator phenotype in colorectal cancer.

  1999cited by this paper
• Targeted cytotoxic analogue of bombesin/ gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice

  1999cited by this paper
• Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant.

  1998cited by this paper
• Differential Expression of Estrogen Receptor-β (ERβ) in Human Pituitary Tumors: Functional Interactions with ERα and a Tumor-Specific Splice Variant1

  1998cited by this paper
• Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

  1997cited by this paper
• Diagnosis and management of nonfunctioning pituitary tumors.

  1996cited by this paper
• Effect of gastrin-releasing peptide (GRP) and GRP antagonists on TSH secretion from rat isolated pituitaries.

  1995cited by this paper
• The cellular retinoic acid binding proteins.

  1995cited by this paper
• Expression of the genes encoding bombesin-related peptides and their receptors in anterior pituitary tissue.

  1993cited by this paper
• The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells.

  1992cited by this paper
• Gastrin-releasing peptide stimulation of corticotropin secretion in male rats.

  1992cited by this paper
• Overexpression of the cellular retinoic acid binding protein-I (CRABP- I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells

  1991cited by this paper
• Evidence for the presence of gastrin-releasing peptide immunoreactivity in rat anterior pituitary corticotrophs and lactotrophs, AtT20 cells, and GH3 cells: failure to demonstrate participation in local control of hormone release.

  1991cited by this paper
• Evidence for a physiological role of hypothalamic gastrin-releasing peptide to suppress growth hormone and prolactin release in the rat.

  1988cited by this paper
• Molecular Cancer Dna Methylation Profiling of Ovarian Carcinomas and Their in Vitro Models Identifies Hoxa9, Hoxb5, Scgb3a1, and Crabp1 as Novel Targets

  year unknowncited by this paper

• MicroRNAs and Target Genes in Pituitary Adenomas

  2018cites this paper
• Gene expression in prolactinomas: a systematic review

  2016cites this paper
• CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid

  2015cites this paper
• Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.

  2015cites this paper
• Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets

  2014cites this paper
• The experimental study of miRNA in pituitary adenomas.

  2013cites this paper